Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Enamel Lesion Detection With New DX Tool

NCT: NCT07819370 · NOT_YET_RECRUITING

NCT IDNCT07819370
StatusNOT_YET_RECRUITING
Start Date2026-09-15
Completion2026-12-20
SponsorColgate Palmolive (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of this 12-week study is to test BlueCheck's ability to identify enamel lesions consistently, and its ability to track changes in these lesions over time.

Frequently Asked Questions

What is Enamel Lesion Detection With New DX Tool?

Enamel Lesion Detection With New DX Tool is a clinical trial registered under NCT07819370. Current status: NOT_YET_RECRUITING.

What is the status of NCT07819370?

The current status of NCT07819370 (Enamel Lesion Detection With New DX Tool) is: NOT_YET_RECRUITING.

When did Enamel Lesion Detection With New DX Tool start?

Enamel Lesion Detection With New DX Tool started on 2026-09-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.